Cynthia Brinson Selected Research

Cynthia Brinson Research Topics

9	Infections 01/2021 - 01/2014
3	COVID-19 09/2022 - 11/2021
3	Headache (Headaches) 01/2019 - 01/2014
2	HIV Infections (HIV Infection) 05/2024 - 01/2021
2	Disease Progression 01/2022 - 11/2021
2	Diarrhea 01/2022 - 01/2016
2	Coinfection 01/2020 - 01/2015
2	Hepatitis B 01/2019 - 11/2016
1	Dysbiosis 05/2024
1	Viremia 01/2024
1	Pneumonia (Pneumonitis) 01/2022
1	Weight Gain 01/2020
1	Injection Site Reaction 01/2020
1	Nausea 01/2019
1	Nasopharyngitis 01/2018
1	Urticaria (Hives) 01/2017
1	Chronic Hepatitis B 11/2016
1	Digestive System Diseases 10/2015
1	Hepatitis 01/2015

7	tenofovir alafenamideIBA 01/2020 - 04/2016
7	Emtricitabine (Emtriva)FDA Link 01/2020 - 04/2016
5	dolutegravirIBA 01/2020 - 01/2017
4	bictegravirIBA 01/2020 - 01/2017
3	Lamivudine (Epivir)FDA Link 01/2020 - 01/2018
3	abacavir (Ziagen)FDA Link 01/2020 - 01/2018
2	vesatolimodIBA 05/2024 - 01/2021
2	Neutralizing AntibodiesIBA 01/2022 - 11/2021
2	sotrovimabIBA 01/2022 - 11/2021
2	Rilpivirine (TMC-278)IBA 01/2021 - 01/2020
2	cabotegravirIBA 01/2021 - 01/2020
2	HLA-B Antigens (HLA-B)IBA 01/2020 - 01/2019
2	Tenofovir (Viread)FDA Link 01/2020 - 04/2016
2	fostemsavirIBA 10/2015 - 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	casirivimab and imdevimab drug combinationIBA 09/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Monoclonal AntibodiesIBA 11/2021
1	lamivudine drug combination abacavir FDA Link 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	CholesterolIBA 01/2020
1	rilpivirine drug combination dolutegravirIBA 01/2018
1	LipidsIBA 01/2018
1	emtricitabine tenofovir alafenamideIBA 11/2016
1	CobicistatIBA 11/2016
1	TabletsIBA 11/2016
1	elvitegravirIBA 11/2016
1	RacivirIBA 01/2016
1	Ritonavir (Norvir)FDA Link 10/2015
1	Atazanavir Sulfate (Reyataz)FDA Link 10/2015
1	RNA (Ribonucleic Acid)IBA 01/2015

2	Therapeutics 01/2021 - 01/2020
1	Art Therapy 05/2024
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Injections 01/2020